CG Oncology (CGON) News Today $30.94 +2.27 (+7.92%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$30.42 -0.52 (-1.68%) As of 04:50 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CGON Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period ADAR1 Capital Management LLC Purchases 85,384 Shares of CG Oncology, Inc. $CGONSeptember 4 at 7:41 AM | marketbeat.comCG Oncology Completes Rapid Enrollment in Phase 3 Study for Intermediate-Risk Non-Muscle Invasive Bladder CancerSeptember 3 at 8:31 AM | quiverquant.comQCG Oncology Completes Enrollment in PIVOT-006September 3 at 8:00 AM | globenewswire.comTema Etfs LLC Has $701,000 Stock Holdings in CG Oncology, Inc. $CGONAugust 31, 2025 | marketbeat.comWalleye Capital LLC Sells 142,315 Shares of CG Oncology, Inc. $CGONAugust 31, 2025 | marketbeat.comNuveen LLC Takes Position in CG Oncology, Inc. $CGONAugust 30, 2025 | marketbeat.comCG Oncology’s Executive Leadership to Participate in Upcoming Investor ConferencesAugust 30, 2025 | finance.yahoo.comWellington Management Group LLP Increases Stock Position in CG Oncology, Inc. $CGONAugust 26, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Has $10.76 Million Stake in CG Oncology, Inc. $CGONAugust 26, 2025 | marketbeat.comVanguard Group Inc. Has $142.93 Million Stake in CG Oncology, Inc. $CGONAugust 23, 2025 | marketbeat.comFox Run Management L.L.C. Makes New $408,000 Investment in CG Oncology, Inc. $CGONAugust 21, 2025 | marketbeat.comPiper Sandler Initiates Coverage of CG Oncology (CGON) with Overweight RecommendationAugust 20, 2025 | msn.comH.C. Wainwright Reiterates a Buy on CG Oncology (CGON), Keeps the PTAugust 20, 2025 | msn.comCG Oncology’s Bladder Cancer Drug Shows Strong Clinical Data, Drives Optimism Despite Price Target CutAugust 20, 2025 | msn.comPiper Sandler initiates coverage of oncology companiesAugust 19, 2025 | msn.comCG Oncology initiated with an Overweight at Piper SandlerAugust 19, 2025 | msn.comQ3 Earnings Estimate for CG Oncology Issued By HC WainwrightAugust 16, 2025 | marketbeat.comCantor Fitzgerald Lowers Earnings Estimates for CG OncologyAugust 15, 2025 | marketbeat.comCG Oncology, Inc. (NASDAQ:CGON) Given Average Recommendation of "Buy" by BrokeragesAugust 12, 2025 | marketbeat.comCG Oncology price target lowered to $62 from $63 at BofAAugust 11, 2025 | msn.comCG Oncology (NASDAQ:CGON) Releases Quarterly Earnings ResultsAugust 11, 2025 | marketbeat.comCG Oncology’s Strategic Advancements and Promising Data Reinforce Buy RatingAugust 11, 2025 | tipranks.comCG Oncology (NASDAQ:CGON) Rating Lowered to "Sell" at Wall Street ZenAugust 10, 2025 | marketbeat.comCG Oncology’s Q2 2025: Clinical Advances and Legal WinsAugust 8, 2025 | tipranks.comBuy Rating for CG Oncology, Inc. Driven by Promising Clinical Data and Strategic AdvancementsAugust 8, 2025 | tipranks.comCG Oncology Reports Second Quarter 2025 Financial Results and Provides Business UpdatesAugust 8, 2025 | globenewswire.comCG Oncology (CGON) Projected to Release Earnings on ThursdayAugust 7, 2025 | marketbeat.comTD Asset Management Inc Sells 10,878 Shares of CG Oncology, Inc. (NASDAQ:CGON)August 5, 2025 | marketbeat.comCG Oncology, Inc. (CGON) Reports 75.5% Complete Response in Bladder Cancer TrialJuly 31, 2025 | msn.comCG Oncology (NASDAQ:CGON) Shares Gap Up - What's Next?July 31, 2025 | marketbeat.comBank of New York Mellon Corp Has $3.61 Million Stock Holdings in CG Oncology, Inc. (NASDAQ:CGON)July 27, 2025 | marketbeat.comTeachers Retirement System of The State of Kentucky Buys Shares of 24,723 CG Oncology, Inc. (NASDAQ:CGON)July 26, 2025 | marketbeat.comCG Oncology (NASDAQ:CGON) Shares Gap Down - Here's WhyJuly 22, 2025 | marketbeat.comInsider Selling: CG Oncology, Inc. (NASDAQ:CGON) Director Sells 2,000 Shares of StockJuly 19, 2025 | marketbeat.comCG Oncology, Inc. (NASDAQ:CGON) Director Leonard E. Post Sells 2,000 SharesJuly 19, 2025 | insidertrades.comCG Oncology, Inc. (NASDAQ:CGON) Receives Consensus Rating of "Buy" from BrokeragesJuly 18, 2025 | marketbeat.com1CGON : Beyond The Numbers: 7 Analysts Discuss CG Oncology StockJuly 16, 2025 | benzinga.comCG Oncology (NASDAQ:CGON) Given New $53.00 Price Target at Royal Bank Of CanadaJuly 16, 2025 | marketbeat.comCenterBook Partners LP Sells 32,980 Shares of CG Oncology, Inc. (NASDAQ:CGON)July 15, 2025 | marketbeat.comTimesSquare Capital Management LLC Has $12.67 Million Stock Position in CG Oncology, Inc. (NASDAQ:CGON)July 15, 2025 | marketbeat.comThe Goldman Sachs Group Initiates Coverage on CG Oncology (NASDAQ:CGON)July 10, 2025 | marketbeat.comWall Street Zen Upgrades CG Oncology (NASDAQ:CGON) to HoldJune 27, 2025 | marketbeat.comCGON - CG Oncology Inc Trailing Returns - MorningstarJune 26, 2025 | morningstar.comMCG Oncology: Looking Undervalued Heading Toward FDA Submission (Upgrade)June 23, 2025 | seekingalpha.comCG Oncology, Inc. (NASDAQ:CGON) Receives Average Rating of "Buy" from AnalystsJune 23, 2025 | marketbeat.comCG Oncology stock price target raised to $56 from $52 at Morgan StanleyJune 18, 2025 | investing.comAugust 15th Options Now Available For CG Oncology (CGON)June 18, 2025 | nasdaq.comCompanies Like CG Oncology (NASDAQ:CGON) Are In A Position To Invest In GrowthJune 18, 2025 | finance.yahoo.comCG Oncology (NASDAQ:CGON) Trading 4.7% Higher After Analyst UpgradeJune 17, 2025 | marketbeat.comCG Oncology (NASDAQ:CGON) Price Target Raised to $56.00 at Morgan StanleyJune 17, 2025 | marketbeat.com Get CG Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CGON and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CGON Media Mentions By Week CGON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CGON News Sentiment▼1.030.71▲Average Medical News Sentiment CGON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CGON Articles This Week▼95▲CGON Articles Average Week Get the Latest News and Ratings for CGON and Related Stocks Enter your email address to receive the latest news and analysts' ratings for CG Oncology and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Roivant Sciences News Today Grifols News Today Revolution Medicines News Today Rhythm Pharmaceuticals News Today Legend Biotech News Today Regencell Bioscience News Today Avidity Biosciences News Today Axsome Therapeutics News Today Abivax News Today Nuvalent News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CGON) was last updated on 9/5/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CG Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CG Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
